Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

Cytokine release syndrome (CRS) is a life-threatening complication of several new immunotherapies used to treat cancers and autoimmune diseases(1–5). Here we report that atrial natriuretic peptide can protect mice from CRS induced by such agents by reducing the levels of circulating catecholamines....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nature
Main Authors: Staedtke, Verena, Bai, Ren-Yuan, Kim, Kibem, Darvas, Martin, Davila, Marco L., Riggins, Gregory J., Rothman, Paul B., Papadopoulos, Nickolas, Kinzler, Kenneth W., Vogelstein, Bert, Zhou, Shibin
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512810/
https://ncbi.nlm.nih.gov/pubmed/30542164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41586-018-0774-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares